Form 8-K - Current report:
SEC Accession No. 0001520138-21-000232
Filing Date
2021-04-29
Accepted
2021-04-29 08:25:01
Documents
32
Period of Report
2021-04-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20210428_8k.htm   iXBRL 8-K 32972
2 EXHIBIT 99.1 bivi-20210428_8kex99z1.htm EX-99.1 9962
6 GRAPHIC bv001_v1.jpg GRAPHIC 186396
7 GRAPHIC bv002_v1.jpg GRAPHIC 253054
8 GRAPHIC bv003_v1.jpg GRAPHIC 181781
9 GRAPHIC bv004_v1.jpg GRAPHIC 138521
10 GRAPHIC bv005_v1.jpg GRAPHIC 111280
11 GRAPHIC bv006_v1.jpg GRAPHIC 181665
12 GRAPHIC bv007_v1.jpg GRAPHIC 138313
13 GRAPHIC bv008_v1.jpg GRAPHIC 194337
14 GRAPHIC bv009_v1.jpg GRAPHIC 177962
15 GRAPHIC bv010_v1.jpg GRAPHIC 195495
16 GRAPHIC bv011_v1.jpg GRAPHIC 145692
17 GRAPHIC bv012_v1.jpg GRAPHIC 190738
18 GRAPHIC bv013_v1.jpg GRAPHIC 230179
19 GRAPHIC bv014_v1.jpg GRAPHIC 169660
20 GRAPHIC bv015_v1.jpg GRAPHIC 207666
21 GRAPHIC bv016_v1.jpg GRAPHIC 127192
22 GRAPHIC bv017_v1.jpg GRAPHIC 162557
23 GRAPHIC bv018_v1.jpg GRAPHIC 129881
24 GRAPHIC bv019_v1.jpg GRAPHIC 186552
  Complete submission text file 0001520138-21-000232.txt   4777156

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bivi-20210428.xsd EX-101.SCH 3102
4 XBRL LABEL FILE bivi-20210428_lab.xml EX-101.LAB 34238
5 XBRL PRESENTATION FILE bivi-20210428_pre.xml EX-101.PRE 22371
25 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20210428_8k_htm.xml XML 3588
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 21867216
SIC: 2834 Pharmaceutical Preparations